IL-37-a putative therapeutic agent in cardiovascular diseases.

McCurdy, S; Yap, J; Irei, J; Lozano, J; Boisvert, W A

McCurdy, S; Yap, J; Irei, J; Lozano, J; Boisvert, W A.

Affiliation

McCurdy S; Department of Medicine, University of California San Diego, San Diego, CA, USA.
Yap J; Department of Medicine, Center for Cardiovascular Research, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI, USA.
Irei J; Department of Medicine, Center for Cardiovascular Research, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI, USA.
Lozano J; Department of Medicine, Center for Cardiovascular Research, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI, USA.
Boisvert WA; Department of Medicine, Center for Cardiovascular Research, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI, USA.

QJM ; 115(11): 719-725, 2022 Nov 14.

Article in En | MEDLINE | ID: mdl-33486516

Subject(s)

Cardiovascular Diseases; Receptors, Interleukin-1; Humans; Mice; Animals; Receptors, Interleukin-1/metabolism; Receptors, Interleukin-1/therapeutic use; Interleukin-18/therapeutic use; Cardiovascular Diseases/drug therapy; Interleukin-1/metabolism; Interleukin-1/therapeutic use; Inflammation

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Receptors, Interleukin-1 Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: QJM Journal subject: MEDICINA Year: 2022 Document type: Article Affiliation country: United States Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google